Nursing Elites

1. What is a condition characterized by an abnormal buildup of fluid between the layers of tissue lining the lungs and chest cavity?

• A. Pleural effusion
• B. Pulmonary edema
• C. Atelectasis
• D. Sarcoidosis

Correct answer: A

Rationale: Pleural effusion is the correct answer as it refers to the accumulation of excess fluid between the layers of the pleura surrounding the lungs and chest cavity. This condition can be caused by various factors such as infections, heart failure, or cancer. Pulmonary edema (choice B) involves fluid accumulation in the lungs' air sacs and is not specific to the pleura. Atelectasis (choice C) is the collapse or closure of a lung leading to airless lung tissue and is not related to fluid buildup. Sarcoidosis (choice D) is a condition characterized by the growth of tiny collections of inflammatory cells in different parts of the body, not specifically involving fluid accumulation in the pleural space.

2. What are the pressure-sensitive structures located in the aortic and carotid bodies called?

• A. Baroreceptors
• B. Chemoreceptors
• C. Nociceptors
• D. Mechanoreceptors

Correct answer: A

Rationale: Baroreceptors are the correct answer. Baroreceptors are specialized sensory receptors that detect changes in pressure within blood vessels. They are primarily located in the aortic arch and carotid sinuses, where they play a crucial role in regulating blood pressure. Chemoreceptors (Choice B) are receptors that detect chemical changes, not pressure changes. Nociceptors (Choice C) are responsible for detecting painful stimuli. Mechanoreceptors (Choice D) respond to mechanical stimuli such as touch, pressure, and vibration, but they are not specifically located in the aortic and carotid bodies.

3. What is a type of heart disease that involves the thickening or stiffening of the heart muscle, reducing its ability to pump blood?

• A. Hypertrophic cardiomyopathy
• B. Dilated cardiomyopathy
• C. Restrictive cardiomyopathy
• D. Arrhythmia

Correct answer: A

Rationale: Hypertrophic cardiomyopathy is a type of heart disease characterized by the thickening or stiffening of the heart muscle, leading to a reduced ability to pump blood. This condition is different from dilated cardiomyopathy (choice B), which involves the enlargement and weakening of the heart chambers. Restrictive cardiomyopathy (choice C) is characterized by the stiffening of the heart muscle, affecting its ability to fill with blood properly. Arrhythmia (choice D) refers to abnormal heart rhythms and is not specifically related to thickening or stiffening of the heart muscle, as seen in hypertrophic cardiomyopathy.

4. The nurse is monitoring a client on dobutamine. What adverse effect should the nurse watch for?

• A. Tachycardia
• B. Bradycardia
• C. Hypertension
• D. Respiratory distress

Correct answer: A

Rationale: The correct answer is A: Tachycardia. Dobutamine is a medication that stimulates beta-1 adrenergic receptors in the heart, leading to increased heart rate. Therefore, tachycardia is a common adverse effect that the nurse should monitor for. Choices B, C, and D are incorrect because dobutamine typically does not cause bradycardia, hypertension, or respiratory distress as its primary adverse effects.

5. What is a condition where the heart is unable to pump blood effectively, leading to a buildup of fluid in the lungs and other parts of the body?

• A. Heart failure
• B. Cardiomyopathy
• C. Myocardial infarction
• D. Pulmonary edema

Correct answer: A

Rationale: The correct answer is A: Heart failure. Heart failure occurs when the heart is unable to pump blood effectively, resulting in a buildup of fluid in the lungs and other parts of the body. Choice B, Cardiomyopathy, refers to diseases of the heart muscle, not specifically the inability to pump blood effectively. Choice C, Myocardial infarction, is a heart attack caused by a blocked blood supply to the heart muscle, not directly related to the heart's pumping efficiency. Choice D, Pulmonary edema, is a condition characterized by fluid accumulation in the lungs, often a consequence of heart failure but not the primary condition described in the question.

Similar Questions